Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,at Society Of Nuclear Medicine 2007 Annual Meeting ( CAMBRIDGE Mass.--(BUSINESS WIRE)--Jun ...)

Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,at Society Of Nuclear Medicine 2007 Annual Meeting

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 4, 2007 - Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) announced today that the company will present the results of several preclinical studies at the 54th annual meeting of the Society of Nuclear Medicine (SNM) in Washington, D.C. The presentations include data on Azedra(TM) (Ultratrace (131)I-MIBG), the company's clinical-stage, targeted radiotherapeutic candidate for the treatment of malignant neuroendocrine tumors; Zemiva, its lead molecular imaging pharmaceutical for imaging cardiac ischemia; and MIP-190, its molecular imaging pharmaceutical candidate that targets angiotensin converting enzyme for the detection of heart failure and vascular inflammatory disease. Data on the company's radiolabeled small molecule molecular imaging pharmaceutical, MIP-1072, for the detection and staging of prostate cancer, were presented on June 3rd. -0-

Abstract Title: Formulation comparisons and pharmacokinetics of high

                specific activity Ultratrace 131I-Iobenguane (mIBG)

                for therapy


Authors:        J. F. Kronauge(a1), J. A. Barrett(1), J. Qi(1),

                H. Mok(1), D. H. Hunter(2), C. Bensimon(4),

                S. Oelsner(4), J. P. Norenberg(3), T. Anderson(3),

                S. Gallo(1), S. M. Hiller(1), J. Joyal(1),

                N. S. Lee(1) and J. W. Babich(1);

                1. Molecular Insight Pharmaceuticals, Inc., Cambridge,

                Massachusetts; 2. University of Western Ontario,

                London, Ontario, Canada; 3. University of New Mexico,

                Albuquerque, New Mexico and 4. MDS Nordion, Kanata,

                Ontario, Canada.


Reference #:    335357


Publication No.: 1316 - Scientific Poster Session


Poster Section:  Dosimetry/Radiobiology Posters


Session Info:   "Meet the Author" II: Neurosciences, General Clinical

                Specialties, and Radiopharmaceutical Chemistry Posters

                Monday, June 4

    
'"/>




Page: 1 2 3 4 
Related medicine technology :

1. Molecular Target of Bradmers Neuradiab Further Validated by
Independent Findings
2. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data
on Molecular Imaging Pharmaceutical for Prostate Cancer
3. Amsterdam Molecular Therapeutics BV to present preclinical
proof-of-concept data on its gene therapy AMT-020 to treat acute
intermittent porphyria
4. DNA Therapeutics Reports a Novel Mechanism of Action and a
Biomarker of its Lead Molecule Dbait That Open an Innovative
Pathway-Targeting in Molecular Cancer Therapy
5. Avid Announces Results of AV-1 Molecular Imaging Agent for
Alzheimers Disease Presented at AD/PD Meeting
6. Novel Mechanism Insights and Additional Data on CombinatoRx Drug
Candidates to Be Presented at Upcoming EULAR Meeting
7. CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively
Licensed to Subsidiary, RXi Pharmaceuticals, Described in
Peer-Reviewed Journal
8. Inspiration Biopharmaceuticals Presents Data From Hemophilia
Program at International Society On Thrombosis and Haemostasis
(ISTH) Annual Meeting
9. European Society for Medical Oncology (ESMO) Presents Data from the
Clinical Trial of MediGenes Cancer-Killing Virus in Press
Conference
10. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity
and Safety Profile of Quadramet at International Myeloma Workshop
11. SemBioSys Presents Positive Insulin Data at the American Diabetes
Association Conference

Post Your Comments:

(Date:5/17/2013)... Mass. , May 17, 2013 Boston Scientific ... participate at the annual EuroPCR Scientific Program May 21-24 ... are pleased to present a particularly rich and diversified ... Keith Dawkins , M.D., global chief medical ... trials will be presented, including the NG PROMUS trial, ...

(Date:5/16/2013)... Therapeutics, (Nasdaq: NKTR ) President and Chief Executive ... to present at the upcoming 2013 UBS Global Healthcare Conference ... New York Hotel on Tuesday, May 21, 2013 at 10:00 ... via a Webcast through a link posted in the Investor ... . This Webcast will be available for replay until June ...

(Date:5/16/2013)... OAKS, Calif. , May 16, 2013 Amgen (NASDAQ: ... Life Sciences Conference on Tuesday, May 21, 2013, at the ... City , beginning at 10:00 a.m. Eastern Daylight Time. ... vice president of Research and Development at Amgen, will present ... accessed from the Events Calendar on Amgen,s website, www.amgen.com ...

Breaking Medicine Technology:Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2 Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3 Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4 Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5 Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6 Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7 Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8 Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City 2

[0] Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 [0] Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City [0] Amgen To Present At The UBS Global Life Sciences Conference

... Md., Aug. 1, 2011 /PRNewswire-USNewswire/ – CoMeD ... Nations Environment Programme (UNEP) distributed a revised ... Advocates for mercury-free drugs were gratified to see pharmaceuticals ... the proposed treaty. The Coalition for ...

... 2011 Reportlinker.com announces that a new ... catalogue: Patient Self-Monitoring: Devices, ... http://www.reportlinker.com/p0581171/Patient-Self-Monitoring-Devices-Markets-Players-and-Prospects .html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic ... monitor their own serum levels is deemed ...

Cached Medicine Technology:Global Mercury Treaty May Include Ban on Mercury in Medicine 2 Global Mercury Treaty May Include Ban on Mercury in Medicine 3 Patient Self-Monitoring: Devices, Markets, Players and Prospects 2 Patient Self-Monitoring: Devices, Markets, Players and Prospects 3

Global Mercury Treaty May Include Ban on Mercury in Medicine Patient Self-Monitoring: Devices, Markets, Players and Prospects

(Date:5/19/2013)... (PRWEB) May 20, 2013 Due to ... with online advertising, MileageAds.com has decided to invite bloggers ... through their ad network. , Businesses in the ... success with online marketing, specifically with ad networks. ... information and legal services and are unsure where to ...

(Date:5/19/2013)... physicians are key decisionmakers for nearly half of all ... in reducing health care costs, according to a new ... admissions from the ER increased by 17 percent over ... hospital admissions between 2003 and 2009. Hospital inpatient ... accounting for 31 percent of the nation,s health care ...

(Date:5/19/2013)... New York, NY (PRWEB) May 19, 2013 ... tickets for his two concerts in Vegas in October ... 20th. Additionaly, during the spring and summer months of ... the country. , Whenever people hear “It’s Five ... and hear the voice of Jimmy Buffett inside their heads. ...

(Date:5/19/2013)... (PRWEB) May 19, 2013 Daily Gossip reporters ... 17 Cheat Foods That Burn Fat to a ... readers. , The review is a detailed ... by the writer's recommendation. , The two nutritionists have discovered ... is responsible for the caloric intake and expenditure of our ...

(Date:5/19/2013)... May is officially known as Skin Cancer Awareness ... Australia, the country's forerunner in fashionable children’s sun ... to kick off their month long mission to bring ... staggering number of cancer cases diagnosed each year, the ... out what’s causing the epidemic and how to stop ...

Breaking Medicine News(10 mins):Health News:Mileageads Ad Network Now Invites Bloggers and Business Owners in Mesothelioma Sector to Advertise on Their Ad Network 2 Health News:ER docs are key to reducing health care costs 2 Health News:ER docs are key to reducing health care costs 3 Health News:Jimmy Buffett Las Vegas Tickets: Jimmy Buffett Tickets in Vegas at the MGM Grand on Oct. 19 and Oct. 26 Go on Public Sale Monday, May 20 at 10:00 a.m. Local Time 2 Health News:Jimmy Buffett Las Vegas Tickets: Jimmy Buffett Tickets in Vegas at the MGM Grand on Oct. 19 and Oct. 26 Go on Public Sale Monday, May 20 at 10:00 a.m. Local Time 3 Health News:The "17 Cheat Foods That Burn Fat" Review and Diet Plan Secrets Revealed by Daily Gossip 2 Health News:Leading Children’s Sun Protection Swimwear Company Platypus Australia use Skin Cancer Awareness Month to Help Educate Parents 2 Health News:Leading Children’s Sun Protection Swimwear Company Platypus Australia use Skin Cancer Awareness Month to Help Educate Parents 3

[0] Mileageads Ad Network Now Invites Bloggers and Business Owners in Mesothelioma Sector to Advertise on Their Ad Network [0] ER docs are key to reducing health care costs [0] Jimmy Buffett Las Vegas Tickets: Jimmy Buffett Tickets in Vegas at the MGM Grand on Oct. 19 and Oct. 26 Go on Public Sale Monday, May 20 at 10:00 a.m. Local Time [0] The "17 Cheat Foods That Burn Fat" Review and Diet Plan Secrets Revealed by Daily Gossip [0] Leading Children’s Sun Protection Swimwear Company Platypus Australia use Skin Cancer Awareness Month to Help Educate Parents

... , ... ... ... ...

... ... ... , ... , , ...

... , ... ... , , , , ... ...

... can have strokes, and the strokes can recur, usually ... strokes often go unrecognized the first time, and the ... Pediatric neurologist Rebecca Ichord, M.D., director of the Pediatric ... today on a study of arterial ischemic stroke in ...

... ... previously unrecognized set of targets and biomarkers to battle solid tumors. , ... (Vocus) February 24, 2010 -- Cancer ... to battle solid tumors. , , , , ,The findings center on discovery of ...

... , ... ... ... ...

Kendle Announces Fourth Quarter and Full-Year 2009 Results The Hub, LLC Announces Strategic Acquisition of EIM Corporation Pelosi on Repealing Antitrust Exemption: Health Insurance Companies Will Now Be Playing on the People's Field Children can have recurrent strokes New Cancer-Fighting Strategy Focuses On Signaling Molecules China Cord Blood Corporation Acquires Stake in Shandong Cord Blood Bank

When You Need Optimal Patient Comfort with Minimal Weight at a Nonunion Site...Demand The OrthoPak Noninvasive Bone Growth Stimulator. , ,Most Appropriate for the Proximal Femur, Metatarsal/Tar...

... Pulsed ElectroMagnetic Field (PEMF) bone growth stimulation ... option for long bone and small bone ... cast, orthopedic brace, or clothing without lessening ... in one compact, lightweight unit including success ...

Our products, with carefully researched design features, are tailored to making arthroscopic and ligament reconstructive surgery more reproducible, easier, quicker and safer....

... Cannulated Interference Screws. Optimal ... and graft selection options. ... without deformation, and chamfered ... threaded atraumatic tissue fixation. ...

Medicine Products:

BioElectron Orthopak Physio-Stim Bone Growth Stimulator Interference Screws ABSOLUTE Absorbable Cannulated Interference Screws